The fight against obstructive sleep apnea (OSA) has taken a monumental leap forward. For the first time, the U.S. Food and ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

(Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for ...

New research reveals how sleep apnea may accelerate brain aging and cognitive decline, with experts sharing crucial insights ...

New Guideline Provides Treatment Recommendations for Restless ... a common yet underdiagnosed sleep disorder, contributes to the development of dementia among adults -- particularly women, a ...

The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.

If it suddenly feels like you’re sleeping or feeling groggy more than you’re awake, you may be sleeping too much—also known ...

Scientists have developed several treatments for sleep maintenance insomnia ... and post-traumatic stress disorder (PTSD). Respiratory problems and reduced mobility can also lead to insomnia.

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the ...

Depression, which doctors may call major depressive disorder, is a treatable ... You may need separate treatment for both depression and sleep problems. Common medications for depression like ...

Fatal familial insomnia is a rare brain disorder that targets the brain and nervous system, which can be life-threatening.

“Of importance, if sleep apnea affects the brain health and increases the risk for dementias, then treatment of it can serve ...